![Sara Secall Ruiz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sara Secall Ruiz
Directeur/Membre du Conseil chez Connecta Therapeutics SL
Profil
Ms. Sara Secall Ruiz is a General Partner at Inveready Asset Management SGEIC SA. She is on the Board of Directors at Connecta Therapeutics SL, Oxolife SL, Ability Pharmaceuticals SL, AptaTargets SL, InnoUp Farma SL, AmacaThera, Inc. and AntalGenics SL.
Ms. Secall Ruiz was previously employed as a Sr. Analyst by ChevronTexaco Corp.
She also served on the board at AmacaThera, Inc., Edesa Biotech, Inc., Biotechnology Development for Industry in Pharmaceuticals SLU, Zera Intein Protein Solutions SL, Agrasys SL, Avizorex Pharma SL and Natac Natural Ingredients SA.
She received her undergraduate degree from the University of Barcelona, a graduate degree from Indiana University and an MBA from London Business School.
Postes actifs de Sara Secall Ruiz
Sociétés | Poste | Début |
---|---|---|
Inveready Asset Management SGEIC SA
![]() Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Private Equity Investor | 01/02/2013 |
Connecta Therapeutics SL
![]() Connecta Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019. | Directeur/Membre du Conseil | 01/09/2020 |
Antalgenics SL
![]() Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Directeur/Membre du Conseil | - |
AptaTargets SL
![]() AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Directeur/Membre du Conseil | 01/05/2017 |
Innoup Farma SL
![]() Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Directeur/Membre du Conseil | 01/07/2015 |
Oxolife SL
![]() Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Directeur/Membre du Conseil | 01/07/2020 |
Ability Pharmaceuticals SL
![]() Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Directeur/Membre du Conseil | 01/06/2019 |
AmacaThera, Inc.
![]() AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Sara Secall Ruiz
Sociétés | Poste | Fin |
---|---|---|
Biotechnology Development for Industry in Pharmaceuticals SLU
![]() Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Directeur/Membre du Conseil | 31/12/2021 |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Sara Secall Ruiz
London Business School | Masters Business Admin |
Indiana University | Graduate Degree |
University of Barcelona | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
EDESA BIOTECH, INC. | Health Technology |
CHEVRON CORPORATION | Energy Minerals |
IFFE FUTURA, S.A. | Finance |
Entreprise privées | 12 |
---|---|
Inveready Asset Management SGEIC SA
![]() Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Finance |
Avizorex Pharma SL
![]() Avizorex Pharma SL Medical/Nursing ServicesHealth Services Avizorex Pharma SL develops drugs for the treatment of the dry eye disease. The company was founded by Carlos Belmonte and Sauri Patrick Tresserras in July, 2013 and is headquartered in Barcelona, Spain. | Health Services |
Connecta Therapeutics SL
![]() Connecta Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019. | Commercial Services |
Antalgenics SL
![]() Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Health Technology |
AptaTargets SL
![]() AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Health Technology |
Innoup Farma SL
![]() Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Health Technology |
Agrasys SL
![]() Agrasys SL BiotechnologyHealth Technology Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain. | Health Technology |
Zera Intein Protein Solutions SL
![]() Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
![]() Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |
Oxolife SL
![]() Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Health Technology |
AmacaThera, Inc.
![]() AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Health Technology |
Ability Pharmaceuticals SL
![]() Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Health Technology |